183 related articles for article (PubMed ID: 20147982)
21. Herpes simplex virus-based vectors for the treatment of cancer and neurodegenerative disease.
Latchman DS
Curr Opin Mol Ther; 2005 Oct; 7(5):415-8. PubMed ID: 16248276
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy: progress and challenges.
Meyer F; Finer M
Cell Mol Biol (Noisy-le-grand); 2001 Dec; 47(8):1277-94. PubMed ID: 11838948
[TBL] [Abstract][Full Text] [Related]
23. Non-viral and viral vectors for gene therapy.
Boulaiz H; Marchal JA; Prados J; Melguizo C; Aránega A
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):3-22. PubMed ID: 16171561
[TBL] [Abstract][Full Text] [Related]
24. Genetic therapies for cardiovascular diseases.
Melo LG; Pachori AS; Gnecchi M; Dzau VJ
Trends Mol Med; 2005 May; 11(5):240-50. PubMed ID: 15882612
[TBL] [Abstract][Full Text] [Related]
25. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
[TBL] [Abstract][Full Text] [Related]
26. Viral-based modelling and correction of neurodegenerative diseases by RNA interference.
Raoul C; Barker SD; Aebischer P
Gene Ther; 2006 Mar; 13(6):487-95. PubMed ID: 16319945
[TBL] [Abstract][Full Text] [Related]
27. Technology insight: therapeutic RNA interference--how far from the neurology clinic?
Gonzalez-Alegre P; Paulson HL
Nat Clin Pract Neurol; 2007 Jul; 3(7):394-404. PubMed ID: 17611488
[TBL] [Abstract][Full Text] [Related]
28. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
Zaiss AK; Muruve DA
Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
[TBL] [Abstract][Full Text] [Related]
29. Viral vector-mediated gene transfer for CNS disease.
Snyder BR; Boulis NM; Federici T
Expert Opin Biol Ther; 2010 Mar; 10(3):381-94. PubMed ID: 20132059
[TBL] [Abstract][Full Text] [Related]
30. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
Pringle IA; Hyde SC; Gill DR
Expert Opin Biol Ther; 2009 Aug; 9(8):991-1003. PubMed ID: 19545217
[TBL] [Abstract][Full Text] [Related]
31. Prospects for gene therapy of haemophilia.
Nathwani AC; Davidoff AM; Tuddenham EG
Haemophilia; 2004 Jul; 10(4):309-18. PubMed ID: 15230943
[TBL] [Abstract][Full Text] [Related]
32. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
During MJ; Leone P
Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
[TBL] [Abstract][Full Text] [Related]
33. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR.
Jiang L; Rampalli S; George D; Press C; Bremer EG; O'Gorman MR; Bohn MC
Gene Ther; 2004 Jul; 11(13):1057-67. PubMed ID: 15152187
[TBL] [Abstract][Full Text] [Related]
34. From gene transfer to gene therapy in lysosomal storage diseases affecting the central nervous system.
Poenaru L
Ann Med; 2001 Feb; 33(1):28-36. PubMed ID: 11310936
[TBL] [Abstract][Full Text] [Related]
35. Vectors and delivery systems in gene therapy.
Gardlík R; Pálffy R; Hodosy J; Lukács J; Turna J; Celec P
Med Sci Monit; 2005 Apr; 11(4):RA110-21. PubMed ID: 15795707
[TBL] [Abstract][Full Text] [Related]
36. Progress and prospects: human artificial chromosomes.
Macnab S; Whitehouse A
Gene Ther; 2009 Oct; 16(10):1180-8. PubMed ID: 19710706
[TBL] [Abstract][Full Text] [Related]
37. [Prospects for gene treatment in paediatric neurology].
Bosch A
Rev Neurol; 2002 Jul 16-31; 35(2):158-62. PubMed ID: 12221630
[TBL] [Abstract][Full Text] [Related]
38. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in ocular gene therapy.
Chung DC; Lee V; Maguire AM
Curr Opin Ophthalmol; 2009 Sep; 20(5):377-81. PubMed ID: 19667988
[TBL] [Abstract][Full Text] [Related]
40. The trigeminal retrograde transfer pathway in the treatment of neurodegeneration.
Kyrkanides S; Yang M; Tallents RH; Miller JN; Brouxhon SM; Olschowka JA
J Neuroimmunol; 2009 Apr; 209(1-2):139-42. PubMed ID: 19278737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
